PTX3 and asthma: Even more strikingly, in saline control group, PTX3 deficiency could confer a marked reduction in baseline IL-17A concentration of lung homogenates based on their reported results [18], which is in turn compatible with the increase in IL-17A in BALF by PTX3 administration in both asthma models observed in our study.